6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Smoking Cessation and Nicotine Dependence
Helping individuals break free from nicotine addiction requires a tailored approach that addresses both physiological dependency and behavioral patterns. Smoking cessation and nicotine dependence remain critical topics in addiction medicine due to their high prevalence and significant health impacts. Interventions now blend pharmacologic aids—such as nicotine replacement therapy, bupropion, and varenicline—with behavioral counseling and digital health tools. Socioeconomic factors, mental health, and comorbid addictions can affect quit rates, highlighting the importance of comprehensive care models. Public policies on taxation, advertising, and smoking bans have also influenced cessation efforts. Research continues to explore genetic predispositions and relapse mechanisms to enhance outcomes.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States